Financial burden associated with discordance to intravenous iron therapies in US patients with iron deficiency anemia

BACKGROUND: Iron deficiency anemia (IDA) affects approximately 5 million people in the United States and has a significant impact on human health. Intravenous (IV) iron is indicated for treatment of IDA when oral iron is not effective or not tolerated. Several IV iron products are available, includi...

Descripción completa

Detalles Bibliográficos
Autores principales: Polson, Michael K, Bahrain, Huzefa, Ogden, Jonathan F, Utkina, Karina, Bucco, Ryan A, Khan, Nabeel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Academy of Managed Care Pharmacy 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10394207/
https://www.ncbi.nlm.nih.gov/pubmed/37133430
http://dx.doi.org/10.18553/jmcp.2023.22407

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10394207/
https://www.ncbi.nlm.nih.gov/pubmed/37133430
http://dx.doi.org/10.18553/jmcp.2023.22407

Ejemplares similares